HCW Biologics Inc. Operating Lease, Cost
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseCost · last filed 2024-05-15
- HCW Biologics Inc. operating lease, cost for the quarter ending 2024-03-31 was $28.27K, a 33.33% decline year-over-year.
- HCW Biologics Inc. operating lease, cost for the quarter ending 2023-12-31 was $42.41K, a 25.00% decline year-over-year.
- HCW Biologics Inc. operating lease, cost for the quarter ending 2023-09-30 was $42.41K, a 0.00% change year-over-year.
- HCW Biologics Inc. operating lease, cost for the quarter ending 2023-06-30 was $42.41K, a 0.00% change year-over-year.
- HCW Biologics Inc. operating lease, cost for fiscal 2023 was $169.65K, a 20.00% increase from fiscal 2022.
- HCW Biologics Inc. operating lease, cost for fiscal 2022 was $141.38K.
| Period end | Operating Lease, Cost 3 month | Operating Lease, Cost 6 month | Operating Lease, Cost 9 month | Operating Lease, Cost 12 month |
|---|---|---|---|---|
| 2024-03-31 | $28.27K 10-Q · filed 2024-05-15 | $70.69K derived: sum of 2 quarters · filed 2024-05-15 | $113.10K derived: sum of 3 quarters · filed 2024-05-15 | $155.51K derived: sum of 4 quarters · filed 2024-05-15 |
| 2023-12-31 | $42.41K derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-05-15 | $84.83K derived: sum of 2 quarters · filed 2024-05-15 | $127.24K derived: sum of 3 quarters · filed 2024-05-15 | $169.65K 10-K/A · filed 2024-05-15 |
| 2023-09-30 | $42.41K 10-Q · filed 2023-11-14 | $84.83K derived: sum of 2 quarters · filed 2023-11-14 | $127.24K 10-Q · filed 2023-11-14 | $183.79K derived: sum of 4 quarters · filed 2023-11-14 |
| 2023-06-30 | $42.41K 10-Q · filed 2023-08-11 | $84.83K 10-Q · filed 2023-08-11 | $141.38K derived: sum of 3 quarters · filed 2023-08-11 | $183.79K derived: sum of 4 quarters · filed 2023-08-11 |
| 2023-03-31 | $42.41K 10-Q/A · filed 2023-08-10 | $98.96K derived: sum of 2 quarters · filed 2023-08-10 | $141.38K derived: sum of 3 quarters · filed 2023-08-10 | $183.79K derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-12-31 | $56.55K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28 | $98.96K derived: sum of 2 quarters · filed 2023-03-28 | $141.38K derived: sum of 3 quarters · filed 2023-03-28 | $141.38K 10-K · filed 2023-03-28 |
| 2022-09-30 | $42.41K 10-Q · filed 2022-11-07 | $84.83K derived: sum of 2 quarters · filed 2022-11-07 | $84.83K 10-Q · filed 2022-11-07 | |
| 2022-06-30 | $42.41K 10-Q · filed 2022-08-12 | $56.55K 10-Q · filed 2022-08-12 | ||
| 2022-03-31 | $13.93K 10-Q · filed 2022-05-13 |